RecruitingNCT06939478

AI Powered Mapping Technology for Identifying Arrhythmias

vMap Informed Targeting of Arrythmia Location EP

Sponsor

Heart Rhythm Clinical and Research Solutions, LLC

Enrollment

110 participants

Start Date

Aug 27, 2025

Study Type

OBSERVATIONAL

Conditions

Exploratory, hypothesis-generating study evaluating the impact of vMap on procedural efficiency, acute success, and work flow optimization.

Min Age: 18 Years

Retrospective Arm:
Patients who had a standard of care cardiac ablation (de novo or repeat) where the vMap equipment was used.
The patient can provide written informed consent, if applicable.
The patient is greater than or equal to 18 years old
Prospective Arm:
Patients who had a standard of care cardiac ablation (de novo or repeat) where the vMap equipment was used.
The patient can provide written informed consent, if applicable.
The patient is greater than or equal to 18 years old

Participants who meet any one of the following criteria will be a screen failure and excluded from participation:
Non-inducible arrhythmia (unless pre-mapped via vMap prior to the procedure).
Patients in whom no ablation was performed using the vMap equipment.
Inability to obtain 12-lead ECG of sufficient quality for vMap analysis.
In the opinion of the Investigator, the participant is not suitable and has a contraindication to undergo the ablation procedure.

Interested in this trial?

Get notified about updates and connect with the research team.